Results 141 to 150 of about 359,688 (261)

Changes in Endogenous Growth Substances in the Embryos of Juglans regia During Stratification1 [PDF]

, 1969
George C. Martin, M. Iona, Richard R. Mason, Harold I. Forde   +3 more
openalex   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source

Antibacterial Activity of Bacteriocin-Like Inhibitory Substances (BLIS) of <i>Levilactobacillus brevis</i> PG-11 against <i>Salmonella</i> Typhimurium. [PDF]

J Microbiol Biotechnol
Pan G, Zhao X, Wang C, Tian Y, Gao J, Sha W, Yin B, Dong W.   +7 more
europepmc   +1 more source

On the Detection Method of Growth-inhibiting Substance

, 1941
Yasuyuki Okabe
openalex   +2 more sources

Vigorous Mold Growth in Soils After Addition of Water-Insoluble Fatty Substances [PDF]

, 1965
Frank P. Krause, Willy Lange
openalex   +1 more source

SensRORing cholesterol to drive protumoral myelopoiesis

Molecular Oncology, EarlyView.
Bleve et al. uncover a cholesterol‐driven immune evasion pathway, where RORγ‐dependent myelopoiesis shapes tumor immunosuppression. Targeting RORγ and PCSK9 emerges as a strategy to boost cancer immunotherapy. Protumoral myelopoiesis is a determinant of immunoevasion and tumor spread in many malignancies.
Sara Gennari, Luigi Nezi, Teresa Manzo
wiley   +1 more source

Studies on the Multiplication of Sweet Potato Seedlings, with Special Reference to the Growth Inhibiting Substances in the Tuber. Part II.

, 1943
T. Aoki
openalex   +2 more sources

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

Molecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern, Kristian Holm, Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Corinna Bang, Bjørn Naume, Johannes R. Hov, Jon Amund Kyte   +7 more
wiley   +1 more source

Organoid scaffold materials: research and application. [PDF]

Front Bioeng Biotechnol
Zhang Z, Zhu M, Luo H, Zeng F, Qi Z.
europepmc   +1 more source

Effect of plant growth-promoting substances on vitamin content and reproduction of Lemna

, 1938
Elmer Edward Frahm
openalex   +2 more sources